Results

Total Results: 9,570 records

Showing results for "scenarios".

  1. www.ahrq.gov/sites/default/files/wysiwyg/topics/dxsafety-current-state.pdf
    January 01, 2024 - Current State of Diagnostic Safety: Implications for Research, Practice, and Policy - Issue Brief PATIENT SAFETY e Issue Brief 16 Current State of Diagnostic Safety: Implications for Research, Practice, and Policy This page intentionally left blank. e Issue Brief 16 Current State of Diagnostic Safety: …
  2. www.uspreventiveservicestaskforce.org/Home/GetFile/1/16768/ovarian-cancer-final-evid-review/pdf
    February 01, 2018 - Screening for Ovarian Cancer: An Updated Evidence Review for the USPSTF Evidence Synthesis Number 157 Screening for Ovarian Cancer: An Updated Evidence Review for the U.S. Preventive Services Task Force Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Service…
  3. www.uspreventiveservicestaskforce.org/home/getfilebytoken/2sssC_CV4u5DY_rgjC-FMd
    February 01, 2018 - Screening for Ovarian Cancer: An Updated Evidence Review for the USPSTF Evidence Synthesis Number 157 Screening for Ovarian Cancer: An Updated Evidence Review for the U.S. Preventive Services Task Force Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Service…
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-risk-reduction_research.pdf
    October 25, 2010 - Future Research Needs Document Future Research Needs To Reduce the Risk of Primary Breast Cancer in Women was available for public comment from September 29, 2010, to October 25, 2010. In response to questions and suggestions received, revisions were made in this version to clarify that no incentives were offere…
  5. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/breast-cancer-risk-reduction_research.pdf
    October 25, 2010 - Future Research Needs Document Future Research Needs To Reduce the Risk of Primary Breast Cancer in Women was available for public comment from September 29, 2010, to October 25, 2010. In response to questions and suggestions received, revisions were made in this version to clarify that no incentives were offere…
  6. www.ahrq.gov/sites/default/files/wysiwyg/chsp/compendium/2020-Compendium-TechDoc-rev.pdf
    January 01, 2020 - Compendium of U.S. Health Systems, 2020, Technical Documentation Comparative Health System Performance Initiative: Compendium of U.S. Health Systems, 2020, Technical Documentation Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 5600 Fishers Lane R…
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/indirect-comparisons_research.pdf
    March 01, 2013 - Case Study Comparing Bayesian and Frequentist Approaches for Multiple Treatment Comparisons Methods Research Report Case Study Comparing Bayesian and Frequentist Approaches for Multiple Treatment Comparisons Methods Research Report Case Study Comparing Bayesian and Frequ…
  8. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/indirect-comparisons_research.pdf
    March 01, 2013 - Case Study Comparing Bayesian and Frequentist Approaches for Multiple Treatment Comparisons Methods Research Report Case Study Comparing Bayesian and Frequentist Approaches for Multiple Treatment Comparisons Methods Research Report Case Study Comparing Bayesian and Frequ…
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/COVID-19-pharmaceutical-treatments-rapid-review.pdf
    March 01, 2024 - Rapid Evidence Product: Adverse Events Associated With COVID-19 Pharmaceutical Treatments Rapid Evidence Product Adverse Events Associated With COVID-19 Pharmaceutical Treatments Background and Purpose The purpose of this rapid review is to determine if COVID treatments authorized for emergency use…
  10. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/COVID-19-pharmaceutical-treatments-rapid-review.pdf
    March 01, 2024 - Rapid Evidence Product: Adverse Events Associated With COVID-19 Pharmaceutical Treatments Rapid Evidence Product Adverse Events Associated With COVID-19 Pharmaceutical Treatments Background and Purpose The purpose of this rapid review is to determine if COVID treatments authorized for emergency use…